Shanghai Rongtai Health Tech (603579) — Working Capital to Net Assets Ratio
Shanghai Rongtai Health Tech (603579) has a Working Capital to Net Assets ratio of 51.9% as of March 2026. Working capital of CN¥1.50 Billion (current assets of CN¥2.32 Billion minus current liabilities of CN¥812.47 Million) is measured against net assets of CN¥2.89 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shanghai Rongtai Health Tech (603579) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shanghai Rongtai Health Tech Working Capital to Net Assets (2011–2025)
This chart shows how Shanghai Rongtai Health Tech's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of March 2026, the ratio stands at 51.9%, reflecting working capital of CN¥1.50 Billion against net assets of CN¥2.89 Billion CNY. Check Shanghai Rongtai Health Tech tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Shanghai Rongtai Health Tech (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Rongtai Health Tech from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 603579 market cap overview.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 52.7% | CN¥1.47 Billion | CN¥2.79 Billion | CN¥2.17 Billion | CN¥704.52 Million | ▼ -6.5 pp |
| 2024 | 59.2% | CN¥1.19 Billion | CN¥2.02 Billion | CN¥2.18 Billion | CN¥985.22 Million | ▼ -20.0 pp |
| 2023 | 79.1% | CN¥1.56 Billion | CN¥1.97 Billion | CN¥2.23 Billion | CN¥666.60 Million | ▲ +5.3 pp |
| 2022 | 73.8% | CN¥1.38 Billion | CN¥1.87 Billion | CN¥2.27 Billion | CN¥890.15 Million | ▲ +8.3 pp |
| 2021 | 65.5% | CN¥1.17 Billion | CN¥1.78 Billion | CN¥2.04 Billion | CN¥871.72 Million | ▼ -1.9 pp |
| 2020 | 67.4% | CN¥1.11 Billion | CN¥1.65 Billion | CN¥1.82 Billion | CN¥704.57 Million | ▲ +8.2 pp |
| 2019 | 59.2% | CN¥966.25 Million | CN¥1.63 Billion | CN¥1.73 Billion | CN¥768.07 Million | ▼ -6.6 pp |
| 2018 | 65.8% | CN¥986.14 Million | CN¥1.50 Billion | CN¥1.60 Billion | CN¥610.21 Million | ▲ +1.9 pp |
| 2017 | 63.9% | CN¥884.15 Million | CN¥1.38 Billion | CN¥1.66 Billion | CN¥777.21 Million | ▲ +15.3 pp |
| 2016 | 48.6% | CN¥222.25 Million | CN¥457.14 Million | CN¥793.41 Million | CN¥571.16 Million | ▲ +5.9 pp |
| 2015 | 42.7% | CN¥133.55 Million | CN¥312.77 Million | CN¥468.40 Million | CN¥334.85 Million | ▲ +12.8 pp |
| 2014 | 29.9% | CN¥58.45 Million | CN¥195.25 Million | CN¥291.92 Million | CN¥233.47 Million | ▼ -7.3 pp |
| 2013 | 37.2% | CN¥48.55 Million | CN¥130.52 Million | CN¥208.06 Million | CN¥159.51 Million | ▼ -17.4 pp |
| 2012 | 54.6% | CN¥77.50 Million | CN¥141.94 Million | CN¥165.06 Million | CN¥87.57 Million | ▼ -11.7 pp |
| 2011 | 66.3% | CN¥88.33 Million | CN¥133.29 Million | CN¥170.13 Million | CN¥81.80 Million | — |